glp 1 breast tenderness Highlighting 3 ongoing clinical trials of GLP-1 medications in and endometrial cancer. 1. FITWISE: Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/​HER2 Negative Breast Cancer 2. Tirzepatide Weight Loss What You Need to Know

So before we move quickly to external GLP-1 support, a more important question is: Are we activating endogenous pathways effectively

--- Here are some potential actions covered in the article for payers and employers to take as a result of this shift: Update formulary tiers and step therapy policies (consider the impact on comorbidities) Support members transitioning off GLP-1s after reaching their goals Create differentiated access pathways based on patient risk profiles Monitor realworld outcomes beyond A1C (cardiovascular, renal, adherence) Model the downstream impact on generics and legacy therapies --- Commercial plans are accelerating GLP-1 uptake and favoring the simplicity of a single therapy

The trial, called RECLAIM, is being led by Dr

Eli Lillys first nine months of 2025 underscored the scale of the GLP-1 surge: Mounjaro and Zepbound generated $39.5 billion in revenue and surpasses Mercks Keytruda as the worlds best-selling medicine[5]

Due to the different monitor and light effect, the actual colour of the item might be slightly different from the colour shown on the pictures

But as the number on the scale drops, health and fitness professionals say many us